1. A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients. (March 2015) Authors: Dikopf, Alana; Wood, Kevin; Salgia, Ravi Journal: Expert opinion on drug safety Issue: Volume 14:Number 3(2015:May) Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗